drugset / Trial / NCT03366207

Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)

NCT03366207

Phase 4 Completed 250 enrolled Iterum Therapeutics, International Limited
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, Phase 4, open label, multi-center study of the clinical and microbiologic efficacy of ciprofloxacin for the treatment of uncomplicated urinary tract infections in adult women.

Timeline

Start
2017-12-15
Primary completion
2018-07-31
Completion
2018-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 250 mg Oral